After graduating from ACPHS with a PharmD and MBA in 2020, Nicolas (Nic) James joined UCB, Inc. in Atlanta, GA, for a two-year postdoctoral fellowship program, focused in Global Regulatory Affairs. Nic stayed on as a Regulatory Scientist for a brief time, and in March of 2023, joined Karuna Therapeutics as a Senior Manager of Regulatory Affairs, developing the next generation of medicines for patients living with psychiatric diseases. He is passionate about the development of ACPHS students and the longevity of the College; he is also an avid golfer, and currently lives with his wife and two cats in their new home in central Connecticut.
Christina Lombardi is the cancer care and research clinical pharmacist at St. Peter's Health Partners in Albany, NY. She completed her PGY1 residency at Baystate Medical Center and her PGY2 oncology/hematology residency at Roswell Park Comprehensive Cancer Center. She is a preceptor for PGY1 pharmacy residents and ACPHS students. She is affiliated with the Hematology/Oncology Pharmacy Association (HOPA), American Society of Health-system Pharmacist (ASHP), and New York State Council of Health-System Pharmacist (NYSCHP). Outside of pharmacy, she is a dance teacher, fitness instructor, and an active member of her church community.
Jeff MacDonald is currently Associate Director, Global Regulatory Policy and Intelligence (GRPI) at BeiGene. He, and the GRPI team, deliver focused policy and intelligence analyses to inform innovative regulatory strategies for BeiGene development assets throughout the product lifecycle. Jeff joined BeiGene in Jun 2021 following two years in CMC Regulatory Sciences at Regeneron Pharmaceuticals. At Regeneron, he led the submission strategy for multiple clinical stage oncology assets across the globe, including US, EU, Japan, and China.
After graduating from ACPHS, Rachael earned her Juris Doctor from Quinnipiac University School of Law in 2020 with a concentration in Tax Law. She is a practicing attorney in Connecticut at Cohen and Wolf, P.C. where she specializes in the areas of Tax Law and Trust & Estate Planning. She has been recognized as a Connecticut Super Lawyer “Rising Star” in both 2022 and 2023. In her free time, she serves on the Westport Farmers’ Market Board of Directors.
Rachel Wurth is currently a PhD candidate in the Clinical and Translational Science Track at Mayo Clinic Graduate School of Biomedical Sciences. Rachel is conducting her thesis work in the clinical Biochemical Genetics Laboratory under the mentorship of Devin Oglesbee, PhD, where she is designing an untargeted metabolomics platform to characterize inborn errors of metabolism for the purpose of novel biomarker discovery. Through partnership with the clinical laboratory, Rachel aims to translate discovered biomarkers into novel diagnostic assays that can improve the detection, and prognostic monitoring of individuals with inborn errors of metabolism.